Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions

John Paul Shen, Dongxin Zhao, Roman Sasik, Jens Luebeck, Amanda Birmingham, Ana Bojorquez-Gomez, Katherine Licon, Kristin Klepper, Daniel Pekin, Alex N. Beckett, Kyle Salinas Sanchez, Alex Thomas, Chih Chung Kuo, Dan Du, Assen Roguev, Nathan E. Lewis, Aaron N. Chang, Jason F. Kreisberg, Nevan Krogan, Lei QiTrey Ideker, Prashant Mali

Research output: Contribution to journalArticlepeer-review

242 Scopus citations

Abstract

We developed a systematic approach to map human genetic networks by combinatorial CRISPR-Cas9 perturbations coupled to robust analysis of growth kinetics. We targeted all pairs of 73 cancer genes with dual guide RNAs in three cell lines, comprising 141,912 tests of interaction. Numerous therapeutically relevant interactions were identified, and these patterns replicated with combinatorial drugs at 75% precision. From these results, we anticipate that cellular context will be critical to synthetic-lethal therapies.

Original languageEnglish (US)
Pages (from-to)573-576
Number of pages4
JournalNature Methods
Volume14
Issue number6
DOIs
StatePublished - May 30 2017
Externally publishedYes

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions'. Together they form a unique fingerprint.

Cite this